The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Chemicals And Chemical Products 20 - Manufacture Of Chemicals And Chemical Products
260 jobs Number of planned job losses
Announcement Date
11 October 2024
Employment effect (start)
11 October 2024
Foreseen end date
31 December 2025
Description
As announced on 11 October 2024, the chemical company Evonik Industries will discontinue the production of keto acids for pharmaceutical applications at its Hanau site by the end of 2025. This decision affects 260 of the 3,500 employees at the location.
The business has not been profitable for five years, mainly due to competition from China and the transformation of the chemical industry. Evonik intends to focus on other core businesses. Socially responsible solutions are being sought for the affected employees, including an internal job placement service. The agreed protection against layoffs for operational reasons in Germany remains in effect until the end of 2032.
The previous worldwide restructuring programme of Evonik from 2024 can be found here Evonik-2024-WO.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
